11 June 2013
Cobra Biologics and Novolytics Unveil Successful Development of Bacteriophages Against Bacterial Infection
28 May 2013
Cobra and Recopharma Enter agreement to utilise Cobra’s Cell Line Development Service- MaxXpress
14 May 2013
Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine